GRIFOLS SHARED SERVICES NORTH AMERICA, INC. for GRIFOLS SHARED SERVICES NORTH AMERICA INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 18, 2023 | $320,000 | Replaced |
| 3rd Quarter - Amendment | Oct 19, 2023 | $320,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Apr 19, 2024 | $320,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Educational meetings on Grifols, presence in district/state, and unique cost considerations of plasma medicines; negative impact of the Inflation Reduction Act on Grifols ability to meet future patient need for plasma medicines
Foreign entity interest: Grifols Shared Services North America, Inc. is a wholly owned subsidiary of Grifols SA a Spain based health care company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER HEALEY | — |
Medicare/Medicaid MMM
Issues around implementation of 2022 H.R. 5376 - "Inflation Reduction Act of 2022"
Foreign entity interest: Grifols Shared Services North America Inc., is a wholly owned subsidiary of Grifols SA, a Spain based healthcare company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER HEALEY | — |
Budget/Appropriations BUD
FY2024 Appropriations Request Supporting blood and plasma donation awareness
Foreign entity interest: Grifols Shared Services North America Inc., is a wholly owned subsidiary of Grifols SA, a Spain-based healthcare company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER HEALEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.